There's a lot to think about when considering whether to volunteer for a clinical study. Any clinical study includes risks, which the study doctor will review with you. Make sure you understand the risks before deciding to participate.
Also, this is not a complete overview of study criteria. A study doctor will review your information to see if you qualify.
A new or archived sample of tissue from any tumor site plus blood and urine tests
Radiographic imaging every 9 to 12 weeks
Study visits every 3 weeks
The study drugs, pembrolizumab and ipilmumab, have been FDA-approved for use in certain types of cancer but ipilimumab is not currently FDA approved to treat non-small cell lung cancer. The combination of these two immunotherapies is investigational.